One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1016/0960-894x(95)00417-r
Copy DOI
Export
Save
Share
Cite Publication Date: Oct 1, 1995 | |
 Citations: 4 |
Affiliation: Pfizer (United States)
The discovery of CP-161,242 (5-cyano-1-[3-(N-methylpyrrolidin-2R-ylmethyl)indol-5-yl]benzimidazole), a potent, selective, orally active central serotonin (5-HT 1D) agonist [IC 50 (binding) = 1.3 nM, EC 50 (inhibition of adenylate cyclase) = 42 pM] and benzodiazepine ligand [ IC 50 ( binding) = 3.3 nM], is presented.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
